ID: ALA16054

Max Phase: Preclinical

Molecular Formula: C12H9BrO2

Molecular Weight: 265.11

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1ccc(Cc2ccccc2)c(Br)o1

Standard InChI:  InChI=1S/C12H9BrO2/c13-12-10(6-7-11(14)15-12)8-9-4-2-1-3-5-9/h1-7H,8H2

Standard InChI Key:  HWYSILIDYYDVBR-UHFFFAOYSA-N

Associated Targets(Human)

Chymotrypsin C 381 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 265.11Molecular Weight (Monoisotopic): 263.9786AlogP: 2.99#Rotatable Bonds: 2
Polar Surface Area: 30.21Molecular Species: HBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.39CX LogD: 3.39
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.84Np Likeness Score: 0.09

References

1. Boulanger WA, Katzenellenbogen JA..  (1986)  Structure-activity study of 6-substituted 2-pyranones as inactivators of alpha-chymotrypsin.,  29  (7): [PMID:3806568] [10.1021/jm00157a007]

Source